Effects of Estrogen plus Progestin on Health-Related Quality of Life
Author(s) -
Jennifer Hays,
Judith K. Ockene,
Robert L. Brunner,
Jane Morley Kotchen,
JoAnn E. Manson,
Ruth E. Patterson,
Aaron K. Aragaki,
Sally A. Shumaker,
Robert G. Brzyski,
Andrea Z. LaCroix,
Iris Granek,
Barbara Valanis
Publication year - 2003
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa030311
Subject(s) - medicine , medroxyprogesterone acetate , progestin , vasomotor , estrogen , placebo , quality of life (healthcare) , hormone therapy , gynecology , physical therapy , breast cancer , nursing , cancer , alternative medicine , pathology
The Women's Health Initiative (WHI) and other clinical trials indicate that significant health risks are associated with combination hormone use. Less is known about the effect of hormone therapy on health-related quality of life.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom